HW
EBS icon

Hancock Whitney’s Emergent Biosolutions EBS Stock Holding History

Hancock Whitney’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31,494
Closed -$977K – 622
2022
Q2 		$977K Sell
31,494
-535
-2% -$18.3K 0.04% 315
2022
Q1 		$1.31M Buy
32,029
+22,687
+243% +$1M 0.04% 303
2021
Q4 		$407K Sell
9,342
-858
-8% -$38.8K 0.01% 521
2021
Q3 		$511K Sell
10,200
-13,252
-57% -$803K 0.02% 469
2021
Q2 		$1.48M Sell
23,452
-8,117
-26% -$521K 0.05% 341
2021
Q1 		$2.93M Buy
31,569
+10,093
+47% +$1.03M 0.1% 185
2020
Q4 		$1.92M Buy
21,476
+9,155
+74% +$840K 0.06% 275
2020
Q3 		$1.27M Sell
12,321
-24
-0.2% -$2.59K 0.05% 330
2020
Q2 		$976K Buy
+12,345
New +$920K 0.04% 369
2016
Q3 		– Sell
-24,130
Closed -$679K – 555
2016
Q2 		$679K Buy
24,130
+130
+0.5% +$5.1K 0.03% 406
2016
Q1 		$872 Hold
24,000
– – 0.04% 334
2015
Q4 		$960K Buy
24,000
+1,000
+4% +$34.9K 0.04% 301
2015
Q3 		$655K Buy
+23,000
New +$758K 0.03% 388

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Hancock Whitney's EBS Position: Q3 2022 in Review

Hancock Whitney sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 31,494 shares — an estimated $977K sold.

Hancock Whitney first reported a position in EBS in Q3 2015 and held it in 13 quarters. The position peaked at $2.93M in Q1 2021. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • Hancock Whitney reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • Hancock Whitney sold 31,494 Emergent Biosolutions shares in Q3 2022, an estimated $977K.
  • Hancock Whitney first reported a position in Emergent Biosolutions in Q3 2015 and held it in 13 quarters.
  • Hancock Whitney's Emergent Biosolutions position peaked at $2.93M in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Hancock Whitney's 13F filing for Q3 2022, filed 26 Oct 2022.